JPH08175971A - Pasty wafer - Google Patents

Pasty wafer

Info

Publication number
JPH08175971A
JPH08175971A JP34084794A JP34084794A JPH08175971A JP H08175971 A JPH08175971 A JP H08175971A JP 34084794 A JP34084794 A JP 34084794A JP 34084794 A JP34084794 A JP 34084794A JP H08175971 A JPH08175971 A JP H08175971A
Authority
JP
Japan
Prior art keywords
medicine
wafer
pasty
taste
facilitate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP34084794A
Other languages
Japanese (ja)
Other versions
JP3294033B2 (en
Inventor
Toshihiro Morita
俊博 森田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP34084794A priority Critical patent/JP3294033B2/en
Publication of JPH08175971A publication Critical patent/JPH08175971A/en
Application granted granted Critical
Publication of JP3294033B2 publication Critical patent/JP3294033B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE: To obtain an additive, pasty wafer, intended to facilitate to be administered through its mixing with a medicine for internal use into a paste, capable of improving the fluidity of the medicine in the oral cavity to facilitate swallowing the medicine, thus designed to make such a medicine easy to take as a result of masking the taste, odor etc. thereof. CONSTITUTION: This pasty wafer is obtained by formulating a blend of e.g. high-viscosity type hydroxypropylmethyl cellulose, precipitated silica as consistency regulator and water at the weight ratio of (1:0.5:40) with 0.005wt.% of ethyl p-oxybenzoate as antiseptic, 0.012wt.% of saccharine sodium as flavor, and 0.75wt.% of orange oil as fragrance.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】 内用薬、特に散剤はその味や物
性などにより服用しにくいことがある。また、高齢者や
乳幼児においては散剤のみならず、錠剤やシロップ剤で
さえも服用拒否を示すことがある。本発明は内用薬を服
用し易く変えるための添加剤である。
[Industrial field] Internal medicines, especially powders, may be difficult to take due to their taste and physical properties. In addition, not only powders but also tablets and syrups may be rejected in the elderly and infants. The present invention is an additive for changing the internal medicine to be easy to take.

【0002】[0002]

【従来の技術】 紙状オブラートで包むか、清涼飲料水
などに混合して服用。
[Background Art] Wrapped in a paper-like wafer or mixed with soft drinks and taken.

【0003】[0003]

【発明が解決しようとする課題】 従来の技術ではオブ
ラートが破れたり口腔内に張り付いて飲み下せない、清
涼飲料水に混合したところ容量が多くなり過ぎたり味が
まずくなって飲み残した、などの課題があった。
[Problems to be Solved by the Invention] In the prior art, the oblate broke or stuck to the oral cavity and could not be swallowed, and when mixed with soft drink, the volume became too large or the taste became unpleasant and left uneaten. There was such a problem.

【0004】[0004]

【課題を解決するための手段】 ペースト状にするため
の基剤(例えば高粘度タイプのヒドロキシプロピルメチ
ルセルロース、ゼラチン、でんぷん、デキストラン、ア
ルギン酸塩、カゼインナトリウム、フィブロイン、ポリ
エチレングリコールなど)に必要に応じて粘稠度調節剤
(例えば軽質無水ケイ酸、グリセリンなど)、矯味剤
(例えばショ糖、ブドウ糖、ステビア、アスパルテー
ム、サッカリン、クエン酸など)、芳香剤(例えばオレ
ンジフレーバー、イチゴフレーバー、コーヒーフレーバ
ーなど)、および防腐剤(例えばパラオキシ安息香酸エ
チル、パラオキシ安息香酸メチル、パラオキシ安息香酸
プロピル、パラベン類、ソルビン酸類など)、着色料な
どを添加、混合して本発明のペースト状オブラートを調
製し、その適量を内用薬に添加、混合する。
[Means for Solving the Problems] A base for making a paste (eg, high-viscosity type hydroxypropylmethylcellulose, gelatin, starch, dextran, alginate, sodium caseinate, fibroin, polyethylene glycol, etc.) is added as necessary. Consistency modifiers (eg light anhydrous silicic acid, glycerin etc.), flavoring agents (eg sucrose, glucose, stevia, aspartame, saccharin, citric acid etc.), fragrances (eg orange flavor, strawberry flavor, coffee flavor etc.) , And a preservative (for example, ethyl paraoxybenzoate, methyl paraoxybenzoate, propyl paraoxybenzoate, parabens, sorbic acid, etc.), a colorant, etc. are added and mixed to prepare the pasty wafer of the present invention, and an appropriate amount thereof is added. Internal medicine Add to and mix.

【0005】[0005]

【作用】 内用薬の口腔内における流動性(滑り)の改
善、および味、臭いなどのマスキング。
[Function] Improvement of fluidity (slippage) in the oral cavity of an internal medicine and masking of taste, smell and the like.

【0006】[0006]

【実施例】【Example】

第1例 ペースト状にするための基剤として高粘度タイプのヒド
ロキシプロピルメチルセルロースを用い、これに粘稠度
調節剤として軽質無水ケイ酸を添加した。配合比はヒド
ロキシプロピルメチルセルロース:軽質無水ケイ酸:水
=1:0.5:40とし、さらに防腐剤としてパラオキ
シ安息香酸エチルを0.005%、矯味剤としてサッカ
リンナトリウムを0.012%、芳香剤としてオレンジ
油を0.75%添加して本発明のペースト状オブラート
を調製した。その5gを苦みと臭いの強い散剤1.3g
(消化薬)に添加、混合して服用させた。 第2例 ペースト状にするための基剤としてゼラチンとグリセリ
ンの混合物であるグリセロゼラチンを用いた。ゼラチ
ン:水:グリセリン=5:20:75の組成とし、さら
に防腐剤としてパラオキシ安息香酸エチルを0.005
%、矯味剤としてサッカリンナトリウムを0.012
%、芳香剤としてオレンジ油を0.75%添加して本発
明のペースト状オブラートを調製した。その5gを苦み
と臭いの強い散剤1.3g(消化薬)に添加、混合して
服用させた。
First Example A high-viscosity type hydroxypropylmethylcellulose was used as a base material for forming a paste, and light anhydrous silicic acid was added to this as a viscosity adjusting agent. The compounding ratio was hydroxypropylmethylcellulose: light anhydrous silicic acid: water = 1: 0.5: 40, and 0.005% ethyl paraoxybenzoate as a preservative, 0.012% sodium saccharin as a flavoring agent, and an aromatic agent. 0.75% of orange oil was added to prepare the pasty wafer of the present invention. 1.3g of powder with strong bitterness and odor
It was added to (digestive), mixed and taken. Second Example Glycerogelatin, which is a mixture of gelatin and glycerin, was used as a base for forming a paste. Gelatin: water: glycerin = 5: 20: 75, and ethyl paraoxybenzoate 0.005 as a preservative.
%, 0.012 saccharin sodium as a corrigent
%, And 0.75% of orange oil as a fragrance were added to prepare the pasty wafer of the present invention. 5 g thereof was added to 1.3 g (digestive) of powder having a strong bitterness and odor, mixed, and taken.

【0007】[0007]

【発明の効果】 内用薬の口腔内における流動性(滑
り)が改善され飲み下すのが容易になった。内用薬の味
や臭いなどがマスキングされ飲み易くなった。また、混
合後の医薬品の容量があまり増えず、しかも少量ずつ服
用できるので飲み残しがなくなった。
EFFECTS OF THE INVENTION The fluidity (slippage) of the internal medicine in the oral cavity was improved and it became easy to swallow. The taste and smell of the internal medicine were masked, making it easier to take. In addition, the volume of the medicine after mixing did not increase so much, and since it could be taken in small amounts, there was no leftover drink.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 内用薬に混せてペースト化し、服用し易
くするための添加剤
1. An additive for making it easy to take by mixing with an internal medicine to form a paste.
JP34084794A 1994-12-24 1994-12-24 Oblate Expired - Lifetime JP3294033B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP34084794A JP3294033B2 (en) 1994-12-24 1994-12-24 Oblate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34084794A JP3294033B2 (en) 1994-12-24 1994-12-24 Oblate

Publications (2)

Publication Number Publication Date
JPH08175971A true JPH08175971A (en) 1996-07-09
JP3294033B2 JP3294033B2 (en) 2002-06-17

Family

ID=18340858

Family Applications (1)

Application Number Title Priority Date Filing Date
JP34084794A Expired - Lifetime JP3294033B2 (en) 1994-12-24 1994-12-24 Oblate

Country Status (1)

Country Link
JP (1) JP3294033B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277395B1 (en) 1998-07-31 2001-08-21 Ryukakusan Co. Ltd. Swallowing-assistive drink
JP2002512953A (en) * 1998-04-29 2002-05-08 住友製薬株式会社 Oral formulation of biguanide drug
USRE39125E1 (en) * 2000-03-13 2006-06-13 Ryukakusan Co. Ltd Swallowing-assistive drink
JP2010195839A (en) * 1998-04-29 2010-09-09 Dainippon Sumitomo Pharma Co Ltd Orally administered preparation of biguanide-based medicine

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002512953A (en) * 1998-04-29 2002-05-08 住友製薬株式会社 Oral formulation of biguanide drug
JP2010195839A (en) * 1998-04-29 2010-09-09 Dainippon Sumitomo Pharma Co Ltd Orally administered preparation of biguanide-based medicine
US6277395B1 (en) 1998-07-31 2001-08-21 Ryukakusan Co. Ltd. Swallowing-assistive drink
USRE39125E1 (en) * 2000-03-13 2006-06-13 Ryukakusan Co. Ltd Swallowing-assistive drink

Also Published As

Publication number Publication date
JP3294033B2 (en) 2002-06-17

Similar Documents

Publication Publication Date Title
JP2874967B2 (en) Pharmaceutical water suspension for drug actives essentially insoluble in water
KR100764531B1 (en) Jellied medicinal composition for oral administration
US4760094A (en) Spray dried acetaminophen
US4835187A (en) Spray dried ibuprofen
KR950009090B1 (en) Pharmaceutical composition containing ibuprofen and aluminium hydroxide
US5712310A (en) Suspension of substantially water-insoluble drugs and methods of their manufacture
SE502285C2 (en) Effervescent pharmaceutical composition containing ranitidine, and process for its preparation
JPS5953410A (en) Novel soft capsule agent
CZ185392A3 (en) Preparation containing megestrol-acetate
TW505525B (en) Pharmaceutical compositions based on diclofenac
JP4309481B2 (en) Jelly oral pharmaceutical composition
JPH08175971A (en) Pasty wafer
CN106170282A (en) Compositions as the aid for oral drugs
JP2001010977A (en) Composition for oral administration
JP5153045B2 (en) Kampo jelly pharmaceutical composition
Sarojini et al. Oral Medicated Jellies–a Review
KR100395864B1 (en) New Pharmaceutical Composition Containing Trimebutine and Process for Preparing It
WO2005011402A1 (en) Masticatable capsule and process for producing the same
KR100293045B1 (en) Sugar-free anhydrous mixed cellulose ether composition as an expandable diarrhea
JPH11322606A (en) Readily swallowable anti-malignant tumor preparation
JP6950312B2 (en) Liquid pharmaceutical compositions and pharmaceuticals
IE51847B1 (en) Pharmaceutical formulation
WO2018155435A1 (en) Granular preparation
JPH01156907A (en) Oral composition for restraint of appetite
RU2237478C2 (en) Antimicrobial pharmaceutical composition

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080405

Year of fee payment: 6

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080405

Year of fee payment: 6

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080405

Year of fee payment: 6

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110405

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term